Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Central Contact Ft. Worth, Texas 76134


Purpose:

The purpose of this study is to investigate the long-term efficacy and safety of posterior juxtascleral injections of open label Anecortave Acetate 15mg administered every 6 months.


Criteria:

Inclusion Criteria: - Patients with subfoveal exudative age-related macular degeneration (AMD) who were previously enrolled in long-term studies with anecortave acetate. - Other protocol-defined inclusion criteria may apply. Exclusion Criteria: - Other protocol-defined exclusion criteria may apply.


NCT ID:

NCT00065728


Primary Contact:

Study Director
Terry Wiernas, PhD
Alcon Research


Backup Contact:

N/A


Location Contact:

Central Contact Ft. Worth, Texas 76134
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 16, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.